The involvement of epigenetics in vascular disease development

Area of Science:

• Cardiovascular Science
• Epigenetics
• Molecular Biology

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of mortality and morbidity.
• Despite advancements, CVD incidence is rising, necessitating a deeper understanding of disease mechanisms.
• Epigenetics, including DNA methylation and histone modifications, regulates gene expression and is crucial for cellular function.

Purpose of the Study:

• To review recent findings on the role of epigenetics in major vascular diseases.
• To focus on DNA methylation and histone modifications in atherosclerosis, restenosis, and aortic aneurysm.
• To highlight the potential of epigenetic mechanisms in cardiovascular pathophysiology and therapeutics.

Main Methods:

• Literature review of recent research on epigenetics and vascular diseases.
• Focus on studies investigating DNA methylation and histone modifications.
• Analysis of epigenetic regulation in atherosclerosis, restenosis, and aortic aneurysm.

Main Results:

• Epigenetic mechanisms, particularly DNA methylation and histone modification, play a fundamental role in cardiovascular physiopathology.
• These epigenetic changes are implicated in the development and progression of atherosclerosis, restenosis, and aortic aneurysm.
• Emerging evidence suggests that epigenetic modifications are amenable to pharmacological manipulation.

Conclusions:

• Epigenetics is crucial for understanding cardiovascular homeostasis and disease pathogenesis.
• Epigenetic-based diagnostic and therapeutic strategies hold promise for managing cardiovascular diseases.
• Targeting epigenetic modifications could offer novel approaches for treating vascular pathologies.